Savara Pharmaceuticals
SVRA
#6601
Rank
S$0.74 B
Marketcap
$4.35
Share price
-1.54%
Change (1 day)
-31.30%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$74.38 Million a decrease over its 2022 earnings that were of -S$51.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion47.83%
2023 -S$74.38 Million43.38%
2022 -S$51.88 Million-11.31%
2021 -S$58.49 Million-13.3%
2020 -S$67.46 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$93.44 Million105.54%
2017 -S$45.46 Million34.11%
2016 -S$33.9 Million-37.43%
2015 -S$54.18 Million38.81%
2014 -S$39.03 Million33.62%
2013 -S$29.21 Million38.49%
2012 -S$21.09 Million24.59%
2011 -S$16.93 Million-36.5%
2010 -S$26.66 Million-3.14%
2009 -S$27.53 Million-23.28%
2008 -S$35.88 Million8.52%
2007 -S$33.06 Million-34.14%
2006 -S$50.2 Million184.43%
2005 -S$17.65 Million90.75%
2004 -S$9.26 Million190.35%
2003 -S$3.19 Million11.64%
2002 -S$2.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$24.69 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.17 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA